menu search

Abbvie boosts its dividend: is the dividend king a buy?

Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year....

November 23, 2022, 5:20 am

Gilead sciences: best near-term biopharma cap gain bet say market-makers

pharmaceuticals producer and developer competitor activities often are hard to separate and the rapid d...

November 23, 2022, 2:30 am

Tff pharmaceuticals: from undefeatable to speculative

Almost everything has gone wrong since my first bullish article with TFF pharmaceuticals. The stock is ...

November 22, 2022, 10:42 pm

Supernus to present at the piper sandler 34th annual healthcare conference

ROCKVILLE, Md., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Supernus pharmaceuticals, Inc. (Nasdaq: SUPN), a bio<...

November 22, 2022, 5:00 pm

Regeneron: stock priced too high to buy, but keep one eye on this pharma

Regeneron pharmaceuticals, Inc. had a strong Q3 even if there are no longer sales of COVID therapy REGE...

November 22, 2022, 2:08 pm

2 reasons to buy abbvie stock and 1 reason to sell

The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a perm...

November 22, 2022, 9:45 am

Spero therapeutics to present at the 5th annual evercore isi healthconx conference

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage bio...

November 22, 2022, 8:05 am

Altimmune to participate at two upcoming investor conferences

GAITHERSBURG, Md., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...

November 22, 2022, 7:30 am

Skye bioscience to present at rhk 2022 disruptive growth conference

San Diego, California--(Newsfile Corp. - November 22, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a ...

November 22, 2022, 7:00 am

Abbvie: paid to wait

AbbVie is a global biopharmaceutical company with a large portfolio of drugs and therapies. Its most su...

November 22, 2022, 4:05 am

Schrödinger: a strong player in the field of drug development technology

Schrödinger's revenue is growing due to its consistent market share growth. The company's software platform is used by the company's multidisciplinar...

November 22, 2022, 1:35 am

Aridis pharmaceuticals (ards) reports q3 loss, misses revenue estimates

Aridis pharmaceuticals (ARDS) delivered earnings and revenue surprises of -4,100% and 96.44%, respectiv...

November 21, 2022, 9:04 pm

Enanta pharmaceuticals (enta) reports q4 loss, lags revenue estimates

Enanta pharmaceuticals (ENTA) delivered earnings and revenue surprises of 7.30% and 9.75%, respectively...

November 21, 2022, 6:48 pm

Paratek pharmaceuticals to present at the 5th annual evercore isi healthconx conference

BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Paratek pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-st...

November 21, 2022, 4:05 pm

Why vertex pharmaceuticals (vrtx) is a top value stock for the long-term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

November 21, 2022, 11:17 am

C-suite shakeup pressures teva pharmaceutical stock

Teva pharmaceutical Industries Ltd  (NYSE:TEVA) is down 2.1% at $8.54 at last check, after the company...

November 21, 2022, 10:49 am

Teva stock alert: what to know about teva pharmaceuticals' new ceo

Teva pharmaceuticals (NYSE: TEVA ) stock is sliding on Monday after the company announced Richard Franc...

November 21, 2022, 10:37 am

Merck making moves, to acquire imago biosciences

Merck & Co., Inc. (NYSE:MRK) is set to acquire biopharmaceutical company Imago Biosciences Inc (NASDAQ...

November 21, 2022, 9:05 am

Tracon pharmaceuticals doses first patient in drug trial to treat malignant tumours

TRACON pharmaceuticals Inc (NASDAQ:TCON) said it has dosed the first patient in a Phase 1/2 trial eval...

November 21, 2022, 8:41 am

Teva names former sandoz chief richard francis as new ceo

Teva pharmaceutical Industries Ltd. TEVA, +0.93% on Monday said its current CEO Kåre Schultz will reti...

November 21, 2022, 7:16 am


Search within

Pages Search Results: